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Abstract Immunofluorescence and subcellular fractionation 
localize annexin I and the EF hand protein S100C to the same 
membranous structures which in part correspond to transferrin 
receptor-positive endosomes. The association of S100C with 
endosomal membranes is strictly dependent on annexin I binding 
since a D91stop-S100C mutant protein, in which the residues 
essential for annexin I binding have been removed, fails to co-
localize with membraneous structures. This indicates that 
annexin I and S100C form a complex in vivo and that the 
endosomal localization of this complex is mediated through an 
interaction of annexin I with the endosomal membrane. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Annexins comprise a multigene family of soluble proteins 
which interact in a Ca2+ dependent manner with phospho-
lipids and intracellular membranes. Structurally, members of 
the family are characterized by repeats of a highly conserved 
70-80 amino acid segment, the annexin repeat, which har-
bours a novel type of Ca2+ binding site [1]. Typically four 
of the annexin repeats form a highly conserved protein core 
domain. This core is preceded by a N-terminal domain unique 
in length and sequence within a given annexin protein [2]. The 
variable N-terminal domain is thought to determine the spe-
cific function of each annexin since it contains phosphoryl-
ation sites for different protein kinases and/or binding sites 
for protein ligands [3]. 
Annexins are present on most intracellular membranes and 
various members have been implicated in different membrane 
transport events [4,5]. These include the sorting of transport 
vesicles to the apical plasma membrane in MDCK cells which 
seems to depend on annexin Xlllb [6]. Annexin II; on the 
other hand, is a major component of early endosomes which 
are capable of homotypic fusion [7] and it regulates the dis-
tribution of early endosomes in vivo [8]. Furthermore, annex-
in II seems to play a major role in a Ca2+ dependent fusion 
process between early endosomes [9]. Another annexin possi-
bly involved in endocytic processes is annexin I. It is a major 
substrate of the EGF receptor kinase and phosphorylation 
occurs in multivesicular bodies, endosomal structures impli-
cated in the sorting of molecules destined for degradation to 
late endosomes/lysosomes [10,11]. Therefore annexin I has 
been linked to the inward vesiculation in multivesicular bodies 
and thus to the sorting of the EGF receptor to the degradative 
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pathway [11]. Moreover, annexin I is specifically localized on 
early endosomes and might be involved in the structural or-
ganization of these membranes [12]. 
Conceptually, different intracellular activities of annexins 
could be specified through the unique N-terminal domains 
which could interact with regulatory protein ligands specific 
for individual annexins. Such annexin protein complexes exist 
and in three cases members of the annexin family have been 
shown to interact through their N-terminal domains with 
members of the SI00 family of small dimeric EF hand type 
Ca2+ binding proteins [13]. Annexin XI binds S100A6 [14], 
annexin II forms a complex with p l l [15] and annexin I in-
teracts with S100C [16,17]. The annexin II pi 1 and annexin 
I-S100C complexes show a high structural similarity since the 
same regions of the respective proteins are involved in com-
plex formation. However, only the annexin II pi 1 complex 
has been characterized in vivo. A detailed analysis of the 
subcellular location and the characterization of the fate of 
ectopically expressed annexin II mutants revealed that annex-
in l i p 11 complex formation is a prerequisite for anchoring 
annexin II in the cortical cytoskeleton of cultured cells [18,19]. 
While the structural requirements of the annexin I-S100C 
complex formation are well characterized in vitro [16,17], very 
little is known about the pysiological relevance of this inter-
action. Therefore we analyzed the annexin I-S100C complex 
formation within cells. By characterizing the intracellular dis-
tribution of annexin I, S100C and ectopically expressed 
S100C mutants impaired in annexin I binding we show that 
annexin I forms a complex with S100C in vivo and that this 
complex is localized on early endosomal membranes. 
2. Materials and methods 
2.1. Cell culture and transfection 
LLCPK and BHK cells were grown in DME (Gibco-BRL) supple-
mented with 10% FCS (Sigma) at 37°C and 5% C02 in a humidified 
atmosphere. For transient transfections the wt-SlOOC cDNA [17] and 
the D91stop-S100C mutant cDNA (lacking residues 91-99 and thus 
the annexin I-binding site [17]) were cloned into the pCMV5 vector to 
yield the constructs pCMV S100C and pCMV D91stop S100C, re-
spectively. The expression constructs encoding the human transferrin 
receptor (pCMV hTfR) and porcine annexin I (pCMV Anxl) have 
been described [8,12,20]. LLCPK cells were transiently transfected 
with pCMV hTfR using the LipofectAmin system (Gibco-BRL) ac-
cording to the manufaturer's instructions. BHK cells were transiently 
transfected with one S100C expression construct (pCMV S100C, 
pCMV D91stop S100C) and pCMV Anxl or pCMV hTfR using the 
modified calcium phosphate precipitation method [21]. The BHK cells 
were transfected at 50% confluence in 100 mm dishes with 15 ug 
plasmid DNA. After incubation for 12-16 h at 35°C in 3% C02 the 
cells were washed with PBS and then cultivated in fresh medium 
employing normal culture conditions. Thirty-six to 40 h following 
transfection, 30^10% of the total cell population was expressing the 
exogenous proteins, as monitored by immunofluorescence using an 
antibody specifically recognizing the ectopically expressed proteins. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00911-3 
186 /. Seemann et al.lFEBS Letters 413 (1997) 185-190 
2.2. Immunofluorescence 
Following transfection of BHK cells grown on glass coverslips 
hTfR internalization into early and recycling endosomes was stimu-
lated by incubating the transfected cells for 30 min in serum-free 
DME medium and then for 30 min in serum-free medium containing 
20 Ug/ml human transferrin (Boehringer Mannheim). Permeabilization 
and cytosol depletion of BHK cells was then achieved by treatment 
with streptolysin O (SLO; kindly provided by Dr. S. Bhakdi, Univer-
sity of Mainz, Germany) as described [22]. Briefly, the coverslips were 
washed with ice-cold PBS and SLO was bound to the plasma mem-
brane by incubating the cells for 10 min on ice with 50 ul of pre-
activated SLO at a concentration of 5 ul/ml in intracellular transport 
buffer (ICT: 70 mM HEPES/KOH pH 7.0, 78 mM KC1, 4 mM 
MgCl2, 10 mM EGTA, 8.37 mM CaCl2, 1 mM DTT; [23]). Unbound 
SLO was removed by washing twice with ice-cold ICT. The cells were 
permeabilized by incubating the coverslips for 10 min at 37°C in ICT. 
Cytosol was further depleted by washing for 10 min in ice-cold ICT 
and the cells were then fixed for 2 min in —20°C cold methanol. 
LLCPK cells were fixed and permeabilized for 6 min in methanol at 
-20°C. The fixed LLCPK and BHK cells were washed with PBS and 
incubated with the first antibodies in PBS containing 1 mg/ml BSA for 
60 min at 37°C. After washing in PBS, the cells were incubated with 
the secondary antibodies, washed again and mounted in Moviol 4-88 
(Hoechst). Fluorescence analysis was performed using a Zeiss Axio-
phot photomicroscope and images were photographed using a Tri X 
Pan 400 film (Kodak). 
2.3. Fractionation of endosomes 
The fractionation of endosomes was carried out essentially as de-
scibed [24,25]. Briefly, six 10 cm dishes of transfected BHK cells were 
treated with 2 mg/ml horseradish peroxidase (HRP) in internalization 
medium (IM: DME medium with 10 mM HEPES, pH 7.4) at 37°C. 
HRP was endocytosed for 5 min to label early endosomes. To label 
late endosomes, the cells were treated for 5 min with HRP and then 
the HRP was chased along the endocytic pathway by incubating the 
cells for 45 min in IM supplemented with 2 mg/ml BSA [24]. Sub-
sequently, the cells were lysed in homogenization buffer (HB buffer: 
250 mM sucrose, 3 mM imidazole/HCl, pH 7.4) containing protease 
inhibitors (10 Ug/ml aprotinin, 1 ug/ml pepstatin A, 1 ug/ml antipain, 
1 |xg/ml leupeptin, 10 ug/ml trypsin inhibitor, 0.5 mM benzamidine, 
10 uM E-64) and the mixture was centrifuged to obtain a post-nuclear 
supernatant (PNS). The PNS was adjusted to 40.6% sucrose, 3 mM 
imidazole, pH 7.4, and placed at the bottom of a SW60 centrifugation 
tube (Beckman). This was overlaid with 1.5 ml of 35% sucrose, 3 mM 
imidazole/HCl, pH 7.4, then with 1 ml of 25% sucrose, 3 mM imida-
zole/HCl, pH 7.4, and finally with 0.5 ml of HB buffer. All sucrose 
solutions containded the same cocktail of protease inhibitors as the 
HB buffer. The step gradient was centrifuged at 35 000 rpm for 60 min 
at 4°C in a SW60 rotor. The 25% HB (membranes enriched in late 
endosomes/endosomal carrier vesicles), 25-35% (early endosomal 
membranes) and 35^10.6% (heavy membranes) sucrose interphases 
were collected and the activity of the endocytosed HRP present in 
the different fractions was analysed as described [26]. Latency was 
measured to verify the integrity of the isolated endosomes [27]. For 
analysis of the wt- and D91stop-S100C distribution in the gradient, 
proteins present in the individual fractions were concentrated by 
chlorofom/methanol precipitation [28] and 10 ug total protein of 
each fraction [29] were seperated by SDS-polyacryamide gel electro-
phoresis using the tricine buffer system [30]. The proteins were trans-
ferred by electrophoretic blotting (transfer buffer: 50 mM Tris, 50 mM 
boric acid) to polyvinyldifluoride membranes (ProBlott Membranes; 
Applied Biosystems) and analyzed by immunoblotting with a poly-
clonal S100C antibody [31]. 
2.4. Antibodies 
Affinity purification of the rabbit polyclonal S100C antibody [17] 
was performed using purified recombinant S100C coupled to cyano-
gen bromide activated Sepharose (Pharmacia). The human transferrin 
receptor was detected with the monoclonal antibody (mAb) B3/25 
(Boehringer Mannheim). The mouse monoclonal antibody against 
annexin I has been described [12]. For immunoblot analysis peroxi-
dase coupled secondary antibodies (Dako) were used and immuno-
reactive bands were detected using the enhanced chemoluminescence 
system (Amersham). Double immunofluorescence employed rhod-
amine-conjugated goat anti-rabbit IgGs (Dianova) and FITC-coupled 
goat anti-mouse IgGs (Cappel Laboratories) as secondary antibodies. 
3. Results and discussion 
3.1. Intracellular localization of SI00C in LLCPK cells 
We first analyzed the intracellular distribution of S100C in 
LLCPK cells by immunofluorescence microscopy employing 
an affinity purified polyclonal antibody raised against recom-
binantly expressed S100C. The cells were fixed and permea-
bilized with methanol and the high cytosolic pool of S100C 
was depleted by washing with PBS. Labeling for S100C is 
apparent underneath the plasma membrane, in particular at 
sites of cell-to-cell contact and in small dots throughout the 
cytoplasm, which are concentrated in a distinct cluster in the 
perinuclear area (Fig. 1). Since this staining pattern appeared 
similar to the localization of the transferrin receptor (TfR), we 
compared the distribution of S100C directly to that of the 
TfR by double immunofluorescence. The transferrin receptor 
is a marker for early endosomes and accumulates during its 
recycling pathway in an endosomal compartment in the peri-
centriolar region of the cell [32,33]. As the endogenous expres-
sion level of the transferrin receptor in LLCPK cells was too 
low for localization studies, we employed a transient trans-
fection approach to overexpress the transferin receptor. 
Therefore we used an expression plasmid encoding the human 
transferrin receptor (hTfR) which was previously shown to 
yield high expression levels in combination with a proper tar-
geting of hTfR to the correct endosomal compartments [8,20]. 
About 38 h following transfection the cells were subjected to 
double immunofluorescence using antibodies against S100C 
and the ectopically expressed hTfR. Fig. 1 shows that a sig-
nificant fraction of S100C co-localizes with the hTfR positive 
endosomal structures. 
3.2. S100C is enriched in endosomal membrane fractions 
To corroborate the localization of S100C on early/recycling 
endosomal membranes we analyzed subcellular membrane 
fractions of BHK cells for their S100C content. We used 
BHK cells for this analysis since a fractionation method en-
riching for endosomal membranes is well established for these 
cells [24,25]. Since our polyclonal S100C antibody did not 
react with the endogenous hamster (BHK) protein we chose 
a transient transfection approach to express in BHK cells 
porcine S100C which is recognized by the antibody. As moni-
tored by immunofluorescence 40% of the total cell population 
expressed the exogenous protein 40 h following transfection 
(not shown). To label endosomes prior to the subcellular frac-
tionation, the transfected cells were treated either with HRP 
for 5 min (fluid phase uptake into early endosomes) or with 
HRP for 5 min followed by a 45 min chase in marker-free 
medium (HRP transport to late endosomes). Subsequently the 
cells were harvested and cellular membranes were subjected to 
a step gradient fractionation to enrich for endosomal mem-
branes [24,25]. The following immunoblot analysis of the dif-
ferent fractions revealed that S100C is indeed enriched in the 
fractions containing early endosomes (Fig. 2A). 
Thus our morphological and biochemical analyses show 
that at least a large fraction of the membrane bound S100C 
is associated with early endosomes. This is reminiscent of the 
intracellular distribution of annexin I which was recently 
shown to form a complex with S100C in vitro [12,16,17]. Since 
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Fig. 1. Immunofluorescence analysis of the S100C localization in LLCPK cells. LLCPK cells ectopically expressing the human transferrin recep-
tor (hTfR) were fixed and permeabilized by treatment with cold methanol. Cells were then double labeled with antibodies to S100C and hTfR 
and the distributions were visualized by labeling with the appropriate secondary antibodies coupled to rhodamine (S100C) and FITC (TfR) re-
spectively. 
the expression patterns of annexin I and S100C also show a 
high degree of similarity [34-36] it seems likely that the two 
proteins also form complex in vivo. 
3.3. Association of S100C with endosomes depends on the 
annexin I-S100C complex formation 
To determine directly whether S100C and annexin I form a 
complex within the cell we expressed in BHK cells a mutant 
S100C protein incapable of annexin I binding and analyzed 
the subcellular distribution of this mutant. We chose for this 
approach the D91stop-S100C mutant which has suffered a 
deletion of the hydrophobic C-terminal extension encompass-
ing residues 91-99 and thus the binding site for annexin I [17]. 
To detect the mutant protein in transfected BHK cells we 
employed a polyclonal S100C antibody specifically recogniz-
ing the ectopically expressed and not the endogenous protein. 
As revealed by immunofluorescence, the mutant protein 
shows the same high expression rate and level as the transi-
ently expressed wild-type (wt) protein (not shown). However, 
in contrast to transfected wt-SlOOC the mutant protein fails 
Wt 
S100C 
B 
D91stop 
PNS LE EE HM PNS LE EE HM 
Fig. 2. Distribution of wt- and D91stop-S100C among subcellular fractions of BHK cells. A postnuclear supernatant (PNS) prepared from 
BHK cells ectopically expressing wt- or D91stop-S100C was fractionated on a discontinuous flotation gradient. Following centrifugation, frac-
tions enriched in late endosomes/endosomal carrier vesicles (LE), early endosomes (EE) and heavy membranes (HM) were collected. 10 ug of 
total protein of each fraction were sujected to SDS-PAGE followed by immunoblot analysis with an antibody only recognizing the ectopically 
expressed S100C proteins. Note that wt- (A) but not D91stop-S100C (B) is enriched on early endosomal membranes. 
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Fig. 3. Localization of wt- and D91stop-S100C in BHK cells. BHK cells were transiently co-transfected with constructs expressing wt- or 
D91stop-S100C and the human transferrin receptor (hTfR; upper panels) or annexin I (Anxl; lower panels), respectively. After permeablization 
and cytosol depletion by treatment with SLO the cells were fixed and double labeled with antibodies against S100C and annexin I or hTfR, 
respectively. All antibodies recognized only the ectopically expressed and not the endogenous proteins. Only wt- but not D91stop-S100C co-
localizes with annexin I and transferrin receptor-positive endosomes. Arrows mark examples of such co-localizations. 
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to co-fractionate with endosomal membranes (Fig. 2). This is 
not due to possible changes in the endosomal membranes 
which may have resulted from the overexpression of the mu-
tant S100C protein since there were no differences in the dis-
tribution and the quantity of the endocytosed marker HRP 
among the gradient fractions of D91stop- and wt-SlOOC ex-
pressing cells (not shown). These observations indicate that 
the association of S100C with early endosomal membrane 
fractions depends on annexin I binding and that an endoso-
mally localized annexin I-S100C complex is formed in vivo. 
To verify the results of the subcellular fractionation, we 
compared the localization of wt- and mutant-SlOOC in 
BHK cells by double immunofiuorescence analyses. BHK cells 
were transiently co-transfected with plasmids coding for 
S100C and hTfR or those encoding S100C and annexin I, 
respectively. Since there is a high cytosolic pool of S100C in 
BHK cells, the cells were depleted of cytosol by streptolysin O 
permeabilization prior to fixation. This allowed a specific vis-
ualization of the membrane bound pool of S100C and annex-
in I. In a first set of experiments, we compared the distribu-
tion of wt and mutant S100C to that of the hTfR. Fig. 3 
reveals a high degree of colocalization of wt-SlOOC with 
hTfR positive endosomal structures. This localization of the 
transfected S100C is essentially the same as that of endoge-
nous S100C in LLCPK cells (see Fig. 1). However, in BHK 
cells the perinuclear concentration of the hTfR and the S100C 
staining is less evident and more dots are present. This is in 
line with earlier findings on the subcellular distribution of the 
recycling endosomes in BHK and CHO cells [37]. In contrast 
to wt-SlOOC, the D91stop-S100C mutant lacking the annex-
in I binding site does not co-localize with the TfR positive 
membranes indicating that annexin I binding is a prerequisite 
for the early endosomal association of S100C (Fig. 3). As a 
further control, we directly compared the distribution of 
S100C and annexin I. Fig. 3 shows that wt- but not 
D91stop-S100C colocalizes with annexin I. The D91stop-
S100C mutant was removed during the cytosol depletion, 
whereas annexin I and wt-SlOOC remained membrane bound. 
This indicates that binding of S100C to membranes requires 
an interaction with annexin I thus corroborating our bio-
chemical data on the interaction of annexin I and S100C in 
vivo. 
Two other members of the annexin family have been shown 
to interact with SI00 proteins. Annexin XI binds calcyclin [14] 
and annexin II forms a complex with p l l [15]. The annex-
in II-p 11 and annexin I-S100C complexes share the same 
structural principles since the same regions in the respective 
proteins participate in the protein-protein interaction, i.e. in 
each case the unique N-terminal region of the annexin binds 
to the C-terminal extension of the S100 protein. However, the 
annexin I-S100C complex is regulated by Ca2+, whereas p l l 
binds Ca2+ independetly to annexin II [15,17]. Binding of 
Ca2+ to S100C most likely exposes on the surface of the 
protein hydrophobic residues of the C-terminal extension 
which then interact with annexin I. The same C-terminal ex-
tension is also indispensable for the endosomal localization of 
S100C as the mutant lacking this domain fails to show any 
membrane association. 
It seems likely that the formation of the annexin I-S100C 
complex modulates the physiological properties of annexin I. 
In vitro it has been shown that the binding of S100C sup-
presses the phosphorylation of annexin I by protein kinase C 
[38]. Phosphorylation by PKC occurs in the N-terminal do-
main of annexin I and changes the Ca2+ and phospholipid 
binding properties since the Ca2+ concentrations necessary 
for the annexin I dependent aggregation of phospholipid 
vesicles [39] and chromaffin granules [40] are increased. Such 
a regulation by PKC phosphorylation and S100C binding 
could affect the role annexin I has been proposed to play in 
the internal vesiculation process in multvesicular endosomes 
[11] and in the structural organization of early endosomes 
[12]. Since S100C forms a tight homodimer under physiolog-
ical conditions, a following binding of each subunit to one 
annexin I molecule would result in the formation of a hetero-
tetrameric complex. Provided that each annexin I molecule is 
associated with different endosomal membranes or different 
regions of an endosomal compartment the heterotetrameric 
complex could connect these membranes. This physical link-
age could possibly hold the membranes in place for the actual 
fusion process to occur and/or could organize the endosomal 
compartment. 
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